(O-30) ONLINE GROUP THERAPY ASSOCIATED WITH PAROXETINE HYDROCHLORIDE FOR COMPULSIVE SEXUAL BEHAVIOR DISORDER´S TREATMENT: A CASE REPORT

M. Abensur, N. M. Calle Roldán, K. T. Mutti, C. H. N. Abdo
{"title":"(O-30) ONLINE GROUP THERAPY ASSOCIATED WITH PAROXETINE HYDROCHLORIDE FOR COMPULSIVE SEXUAL BEHAVIOR DISORDER´S TREATMENT: A CASE REPORT","authors":"M. Abensur, N. M. Calle Roldán, K. T. Mutti, C. H. N. Abdo","doi":"10.1093/jsxmed/qdae018.024","DOIUrl":null,"url":null,"abstract":"\n \n \n Compulsive Sexual Behaviour Disorder (CSBD) is characterized in ICD-11 as a persistent inability to control intense sexual urges resulting in repetitive sexual behaviours and negative effects in personal life.\n Due to the limited research on CSBD´s treatment, our goal is to report a successful case of 39-year-old symptomatic male patient, treated in a structured closed online group focused on self and CSBD´s knowledge, new habits acquisition, particularities of these patients´ profile, associated with medication use.\n \n \n \n the information in this report were obtained through patient interviews, psychiatric and psychological records and literature review.\n The treatment took place in an outpatient service specialized in sexuality at a public institution. Following CSBD diagnosis, Paroxetine Hydrochloride (20mg/day) was prescribed with regular psychiatric follow-ups. And was referred to an online psychotherapy group consisting of 4 CSBD participants, 2 therapists, weekly 1-hour sessions held for 10 months. The therapy addressed pertinent issues to the treatment and utilized neuropsychoeducational sessions to establish new habits, along with reflective “homework” tasks.\n \n \n \n Psychotherapeutic treatment enhanced self-knowledge leading to a loss of meaning to his compulsive behaviours, therefore, a decrease in its frequency. The patient developed a healthy sexuality, free from guilt and risky behaviours, improved emotional management and diversified interests.\n Paroxetine Hydrochloride (20mg/day) facilitated the psychotherapy process (10 months), allowing gradual dosage reduction upon symptom alleviation.\n \n \n \n The combination of themed online group psychotherapy, a well-established group bond, neuropsychoeducation, and medication effectively addressed CSBD symptoms, enhanced emotional management, and improved quality of life. The positive outcome encourages future research into this treatment approach for CSBD.\n \n \n \n No conflict.\n","PeriodicalId":377411,"journal":{"name":"The Journal of Sexual Medicine","volume":"10 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Sexual Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jsxmed/qdae018.024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Compulsive Sexual Behaviour Disorder (CSBD) is characterized in ICD-11 as a persistent inability to control intense sexual urges resulting in repetitive sexual behaviours and negative effects in personal life. Due to the limited research on CSBD´s treatment, our goal is to report a successful case of 39-year-old symptomatic male patient, treated in a structured closed online group focused on self and CSBD´s knowledge, new habits acquisition, particularities of these patients´ profile, associated with medication use. the information in this report were obtained through patient interviews, psychiatric and psychological records and literature review. The treatment took place in an outpatient service specialized in sexuality at a public institution. Following CSBD diagnosis, Paroxetine Hydrochloride (20mg/day) was prescribed with regular psychiatric follow-ups. And was referred to an online psychotherapy group consisting of 4 CSBD participants, 2 therapists, weekly 1-hour sessions held for 10 months. The therapy addressed pertinent issues to the treatment and utilized neuropsychoeducational sessions to establish new habits, along with reflective “homework” tasks. Psychotherapeutic treatment enhanced self-knowledge leading to a loss of meaning to his compulsive behaviours, therefore, a decrease in its frequency. The patient developed a healthy sexuality, free from guilt and risky behaviours, improved emotional management and diversified interests. Paroxetine Hydrochloride (20mg/day) facilitated the psychotherapy process (10 months), allowing gradual dosage reduction upon symptom alleviation. The combination of themed online group psychotherapy, a well-established group bond, neuropsychoeducation, and medication effectively addressed CSBD symptoms, enhanced emotional management, and improved quality of life. The positive outcome encourages future research into this treatment approach for CSBD. No conflict.
(O-30) 结合盐酸帕罗西汀治疗强迫性性行为障碍的在线小组疗法:病例报告
强迫性性行为障碍(CSBD)在 ICD-11 中被描述为持续无法控制强烈的性冲动,导致重复的性行为和对个人生活的负面影响。由于对 CSBD 治疗的研究有限,我们的目标是报告一个 39 岁男性症状患者的成功案例,该患者接受了结构化封闭式在线小组的治疗,重点是自我和 CSBD 知识、新习惯的养成、这些患者的特征以及与药物使用相关的问题。治疗是在一家公立机构的性学专科门诊进行的。在确诊 CSBD 后,医生给患者开了盐酸帕罗西汀(20 毫克/天),并定期进行心理随访。患者被转介到一个在线心理治疗小组,该小组由 4 名 CSBD 参与者和 2 名治疗师组成,每周进行 1 小时的治疗,为期 10 个月。治疗涉及与治疗相关的问题,并利用神经心理教育课程建立新习惯,以及反思性 "家庭作业 "任务。 心理治疗增强了患者的自我认识,使其丧失了强迫行为的意义,从而降低了强迫行为的频率。患者发展了健康的性生活,摆脱了负罪感和危险行为,改善了情绪管理并培养了多样化的兴趣。盐酸帕罗西汀(20 毫克/天)促进了心理治疗过程(10 个月),在症状缓解后可逐渐减少剂量。 主题在线小组心理治疗、建立良好的小组纽带、神经心理教育和药物治疗相结合,有效地解决了 CSBD 症状,加强了情绪管理,提高了生活质量。这一积极的结果鼓励了未来对 CSBD 治疗方法的研究。 无冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信